"Recombinant Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins prepared by recombinant DNA technology.
| Descriptor ID |
D011994
|
| MeSH Number(s) |
D12.776.828
|
| Concept/Terms |
Recombinant Proteins- Recombinant Proteins
- Proteins, Recombinant
- Proteins, Biosynthetic
- Biosynthetic Proteins
Proteins, Recombinant DNA- Proteins, Recombinant DNA
- DNA Proteins, Recombinant
- Recombinant DNA Proteins
- DNA Recombinant Proteins
- Proteins, DNA Recombinant
- Recombinant Proteins, DNA
|
Below are MeSH descriptors whose meaning is more general than "Recombinant Proteins".
Below are MeSH descriptors whose meaning is more specific than "Recombinant Proteins".
This graph shows the total number of publications written about "Recombinant Proteins" by people in this website by year, and whether "Recombinant Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 31 | 33 |
| 1997 | 1 | 36 | 37 |
| 1998 | 0 | 34 | 34 |
| 1999 | 0 | 38 | 38 |
| 2000 | 1 | 40 | 41 |
| 2001 | 1 | 28 | 29 |
| 2002 | 1 | 42 | 43 |
| 2003 | 2 | 35 | 37 |
| 2004 | 2 | 40 | 42 |
| 2005 | 3 | 32 | 35 |
| 2006 | 1 | 32 | 33 |
| 2007 | 3 | 43 | 46 |
| 2008 | 1 | 32 | 33 |
| 2009 | 5 | 31 | 36 |
| 2010 | 6 | 24 | 30 |
| 2011 | 1 | 33 | 34 |
| 2012 | 3 | 19 | 22 |
| 2013 | 0 | 37 | 37 |
| 2014 | 1 | 26 | 27 |
| 2015 | 1 | 32 | 33 |
| 2016 | 5 | 22 | 27 |
| 2017 | 2 | 29 | 31 |
| 2018 | 2 | 17 | 19 |
| 2019 | 2 | 14 | 16 |
| 2020 | 2 | 20 | 22 |
| 2021 | 2 | 15 | 17 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 6 | 6 |
| 2024 | 1 | 3 | 4 |
| 2025 | 2 | 6 | 8 |
| 2026 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recombinant Proteins" by people in Profiles.
-
Central Administration of Recombinant IGF1 Is Neuroprotective in a Rodent Model of Acute Liver Failure. Int J Mol Sci. 2026 Apr 16; 27(8).
-
Updates on Use and Monitoring of Direct Thrombin Inhibitors. Clin Lab Med. 2026 Jun; 46(2):259-277.
-
Heterologous expression, purification and functional characterization of recombinant serratiopeptidase from Serratia marcescens AD-W2. World J Microbiol Biotechnol. 2026 Feb 24; 42(3).
-
Therapeutic potential of hookworm proteins in promoting regulatory immune responses to modulate Trypanosoma cruzi induced liver inflammation and oxidative stress. Mem Inst Oswaldo Cruz. 2026; 121:e250123.
-
Efficient bioprocess for high-density fermentation and rapid purification of soluble tag-free CRM197 protein expressed in Escherichia coli. Int J Biol Macromol. 2026 Jan; 338(Pt 2):149685.
-
Whole-brain Mapping Reveals Diet-dependent Neuronal Activation and Selective Resistance to Exogenous FGF21. Endocrinology. 2025 12 05; 167(1).
-
Evaluation of a Novel Tc-24 Recombinant Antigen ELISA for Serologic Detection of Trypanosoma cruzi Infection in Dogs: A Pilot Study. Vet Med Sci. 2025 Sep; 11(5):e70570.
-
Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide. Radiat Prot Dosimetry. 2025 Aug 26; 201(13-14):995-1005.
-
Dosing Reliability of Direct Thrombin Inhibitors in Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis. ASAIO J. 2025 09 01; 71(9):691-700.
-
Rapid High-Sensitivity Detection of Antibodies to Trypanosoma cruzi With a Recombinant Tc24 Antigen-Based Magneto-Immunoassay: A Pilot Study. J Infect Dis. 2025 Jul 11; 231(6):e1114-e1118.